TrialInflammatory bowel diseases2026

Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid.

Andres Yarur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.